Pharmaceutical Technology

MARCH 30, 2023

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

Contract Manufacturing 147

Contract Manufacturing Manufacturing Pharma Companies Cosmetics 147

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. Cailiff’s answer was circumspect.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Within this, the progressive pharma companies are utilising modular content to increase brand standards.

Regulation 97

Regulation Marketing Sales Branding 97

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. Outside of pharma, the list included new ads from Revlon and mobile games Dream.

Drugs 105

Drugs Allergies Branding FDA Approval 105

BioPharma Reporter

AUGUST 31, 2023

The moment that major pharma companies have been dreading, since the approval of Biden's Inflation Reduction Act, has arrived.

Pharma Companies 97

Pharma Companies Drugs Regulation Marketing 97

World of DTC Marketing

FEBRUARY 7, 2022

At 99% of pharma companies, that's a huge no-no. On top of this, “the company also revealed that the Federal Trade Commission and the Securities and Exchange Commission had opened two new, separate investigations into the troubled biotech. At 99% of pharma companies, that’s a huge no-no.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Drug Discovery World

MAY 6, 2024

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. The CDD will sponsor and manage KWF-supported trials. billion ($7.9

Drugs 59

Drugs Life Science Gene Editing Gene 59

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. Read below for a preview! .

Drugs 105

Drugs Pharma Companies Licensing Licensing 105

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 98

Drugs Antibody Pharma Companies Development 98

World of DTC Marketing

FEBRUARY 16, 2022

What is pharma’s responsibility? Pharma provides medications to treat everything from severe cardiac issues to depression but should America’s pharma companies go beyond just providing a treatment? People accuse pharma of keeping people sick to make money. Pha a fails in this. That’s a rumor.

Pharma Companies 178

Pharma Companies Regulation Vaccination Vaccine 178

Pharmaceutical Technology

JUNE 5, 2023

Earlier this year, Sun Pharmaceutical Industries , one of India’s largest generic drug producers, reported a major cybersecurity breach , impacting its business operations. Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health.

Compliance 276

Compliance Regulation Pharmacy Genome 276

BioPharma Reporter

FEBRUARY 18, 2021

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Pharma Companies 52

Pharma Companies Development Manufacturing Drugs 52

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data.

Drugs 52

Drugs Marketing Life Science Regulation 52

Fossil Remedies

OCTOBER 16, 2022

When you launch a PCD pharma company , you have to do several preparations. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies. Wholesale Drug License.

Licensing 52

Licensing Licensing Pharma Companies Cosmetics 52

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 The post Team behind RECOVERY trial of COVID drugs casts its net wider appeared first on. million in funding from French drugmaker Sanofi.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

World of DTC Marketing

MARCH 24, 2022

I’ve seen some new energy and thinking taking root in some big pharma companies. Still, I’m also seeing some recycled executives show up at other companies when they should have been removed permanently from the industry. John worked for a division of a major pharma company in Cambridge.

Pharma Companies 213

Pharma Companies HR Sales Regulation 213

pharmaphorum

SEPTEMBER 30, 2021

The new guidance is the first of a series that have been promised by the US regulator to develop a framework for regulating RWD, which is increasingly being used by pharma companies to investigate how their medicines perform beyond the controlled environment of clinical trials.

Pharma Companies 95

Pharma Companies Regulation Clinical Trials Clinical Trials 95

Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. What is Patient-Centricity?

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

pharmaphorum

JULY 28, 2022

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. Many of the medicines most badly affected by these shortages are generic drugs to treat common conditions such as diabetes and heart disease.

Compliance 111

Compliance Drugs Manufacturing Generic Drugs 111

World of DTC Marketing

FEBRUARY 28, 2021

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties.

Vaccination 180

Vaccination Vaccine Contamination Compliance 180

pharmaphorum

JUNE 2, 2022

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. This is why the action by the US in 1983 and subsequently the European Commission Regulation No. It is estimated that between 3.5 The price is right.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

DECEMBER 21, 2021

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. Headway being made. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Dermatology 118

Dermatology Production Pharma Companies Marketing 118

pharmaphorum

NOVEMBER 4, 2020

As an influential panel of FDA-appointed experts prepares its verdict on Biogen’s Alzheimer’s drug, a little known China-based pharma is hoping to succeed where big name rivals have failed and develop a drug that is effective against the disease.

Trials 74

Trials Drugs Bacteria Pharma Companies 74

Camargo

NOVEMBER 11, 2020

When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. However, to invest in drug development for this condition, a number of methodological issues will need to be addressed.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Then there is the cost of generic drugs.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

World of DTC Marketing

JUNE 24, 2021

Safety pages on Pharma product websites continue to have high utility. As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. Prescription drugs are not the same as items found in a grocery store. ” They go online to learn more.

Doctors 165

Doctors Doctor Production Drugs 165

Pharmaceutical Technology

DECEMBER 21, 2022

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery. This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated.

Regulation 351

Regulation Pharma Companies Medicine Clinical Trials 351

pharmaphorum

AUGUST 2, 2022

Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial. Also coming through is Pfizer, which partners with Germany’s Merck KGaA on latecomer PD-L1 drug Bavencio (avelumab).

Trials 105

Trials Marketing Drugs Pharma Companies 105

pharmaphorum

AUGUST 21, 2020

Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial. Could AI prevent future pandemics by developing an armoury of drugs that work against all coronaviruses?

Vaccination 105

Vaccination Vaccine Regulation Manufacturing 105

XTalks

MARCH 28, 2024

Italy-based drugmaker Italfarmaco has won US Food and Drug Administration (FDA) approval for its oral medication Duvyzat (givinostat) for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and older. The drug generated domestic sales of $200.4 million last year, of which $131.3

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

FEBRUARY 1, 2021

The FDA has delayed its decision on aducanumab, the troubled Alzheimer’s drug from Biogen and Eisai by three months, raising hopes that it could be approved after all. The FDA is not bound by the decisions of its advisory boards but it usually follows their advice when making decisions on drugs.

Pharma Companies 96

Pharma Companies Drugs Regulation Development 96

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. We have also seen the regulators actively support the use of these hybrid decentralised research approaches. Each device type has an important role to play in hybrid and DCT trials.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

Drug Discovery World

DECEMBER 27, 2023

You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts. These are just some of the words that come to mind when talking about not just the drug discovery sector, but the lives of those working in and around it. He speaks about this drug discovery journey here. Developing. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

pharmaphorum

JUNE 16, 2022

The two companies say the integrated digital therapeutic (DTx) for breast cancer will aim to promote behaviour modifications to improve the wellbeing of breast cancer patients as well as adherence to drug treatment, foe example by managing side effects.

Hormones 103

Hormones Pharma Companies Regulation Drugs 103

pharmaphorum

JANUARY 6, 2021

Analysts are continuing to back Inventiva’s lanifibranor as a potential “best-in-class” drug for the fatty liver disease NASH, as the company prepares for the launch of a phase 3 trial in spring. A host of other pharma companies including Gilead, Novo Nordisk, Merck & Co are also developing potential NASH drugs.

Gene Silencing 52

Gene Silencing Regulation Pharma Companies Doctors 52